Medical News Observer

Key Points:

• IB Lab LAMA employs deep learning, including convolutional neural networks, to provide fully automated and precise measurements.
• The software is tailored for professional radiological use, enhancing the accuracy of limb and knee measurements.
• The FDA has cleared it as substantially equivalent to its predicate devices.

 

Device Information

IB Lab LAMA is software that automatically processes radiological images. Its purpose is to assist healthcare professionals in measuring limb-length discrepancies and quantitative knee alignment parameters using uni- and bilateral AP full-leg radiographs. This software is designed for use on radiographs of individuals 22 years of age or older. It utilizes artificial intelligence, specifically deep learning technology, including convolutional neural networks and classification technologies, to perform precise, fully automated measurements.

Manufacturer Information

 IB Lab GmbH, headquartered in Vienna, Austria, created this software product. The company specializes in advanced imaging solutions, particularly in the orthopedic sector, aiming to enhance diagnostic accuracy through automated software technologies.

Regulatory Approval Information

IB Lab LAMA has received clearance from the FDA to market its medical device under the 510(k) premarket notification rule. This rule allows it to be marketed if it is substantially equivalent to a predicate device. The device falls under the classification of a Class II medical device, with a product code of QIH.

Indications

This software is indicated for professional use in radiology to aid in measuring limb lengths and knee alignments. It should not replace comprehensive patient evaluations and is not meant to independently make or confirm a diagnosis. The software is unsuitable for radiographs with Ankle Arthroplasty and/or Unilateral Knee Arthroplasty.

Contraindications

This software is not indicated when radiographs include ankle or knee arthroplasties. It is also not advised to use this software as the sole diagnostic tool without clinical evaluation.

Study Results

Clinical studies conducted in the U.S. demonstrated that IB Lab LAMA’s measurements are highly reliable. The studies involved comparisons with ground truths established by expert radiologists, showing substantial agreement and high sensitivity and specificity in detecting arthroplasties.

Limitations

While IB Lab LAMA offers significant benefits in radiological measurements, its limitations include its appropriateness only for certain types of radiographs and its reliance on proper interpretation by trained professionals. 

Conclusion

IB Lab LAMA is a robust tool that enhances the precision of radiological measurements pertinent to orthopedic evaluations. It is substantially equivalent to previously approved devices and adheres to rigorous safety and effectiveness standards, as confirmed by the FDA.

Future Implications

As diagnostic technologies evolve, tools like this may be crucial in integrating artificial intelligence with clinical practice to improve diagnostic accuracies and patient outcomes. 

References

• “IB Lab LAMA K223646 510(k) Premarket Notification.” Accessed May 2, 2024. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K223646
• “Image Biopsy products.” Accessed May 2, 2024. https://www.imagebiopsy.com//product/lama-ce.